In patients undergoing carotid endarterectomy under general anaesthesia, does superficial cervical plexus blockade with the local anaesthetic bupivicaine affect post-operative blood pressure control?

ISRCTN ISRCTN41318293
DOI https://doi.org/10.1186/ISRCTN41318293
Secondary identifying numbers N0227149022
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
17/04/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Gerry Danjoux
Scientific

South Tees Hospital Trust
The James Cook University Hospital
Anaesthetics Department
Cheriton House
Marton Road
Middlesbrough
TS4 3BW
United Kingdom

Email abc@email.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleIn patients undergoing carotid endarterectomy under general anaesthesia, does superficial cervical plexus blockade with the local anaesthetic bupivicaine affect post-operative blood pressure control?
Study objectivesIn the early post-operative period following carotid endarterectomy, patients commonly develop blood pressure liability. It is our observation that over the last 2 years the incidence of severe hypertension requiring treatment appears to have decreased whilst the incidence of hypotension appears to be increasing. There are two main changes to our practice that may be contributing to this observation: Firstly, the vast majority of our patients are now beta-blocked as this has been shown to improve outcome in patients undergoing vascular surgery. Secondly, our patients are now commonly given a superficial cervical plexus block in addition to a general anaesthetic as part of a multi-modal approach to post-operative analgesia. We would like to look at the influence of superficial cervical plexus blockade on post-operative blood pressure control in these patients.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Carotid endarterectomy
InterventionAll patients undergoing carotid endarterectomy will receive a standardised general anaesthetic.

The patients in the study will be randomised to the treatment group who will receive a superficial cervical plexus block, or to a control group receiving no block.

This block will be performed in the anaesthetic room following induction of anaesthesia by the responsible anaesthetist using a standard block technique. Following surgery the patients will be monitored in recovery in the usual manner until stable before being transferred to the high dependency unit for the first 24 hours following surgery. Any pain will be treated with intravenous opiates or simple analgesics as appropriate. Blood pressure persistently greater than 160mmHg will be treated with labetolol or GTN. Hypotension persistently below 100mgHg will be treated with a fluid challenge and phenylephrine, according to the current HDU guidelines.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Bupivicaine
Primary outcome measureMean systolic blood pressure over the first 24 hours following surgery.
Secondary outcome measuresSecondary outcomes will include the need for vasopressor or antihypertensive medication, cumulative opiate requirements, and mean pain scores in recovery and HDU.
Any major cardiovascular or cerebrovascular morbidity or mortality in the first 24 hours, and any side effects potentially related to the block will be recorded.
Overall study start date01/09/2004
Completion date30/09/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants54
Key inclusion criteriaThe patients will be selected from all patients presenting for carotid endarterectomy. The vast majority of these patients are now seen in the vascular preadmission clinic by a consultant anaesthetist. This clinic will provide the opportunity to discuss the project with the patients. They would then be able to consider at home prior to admission whether or not to participate. Consent where relevant would then be taken at the time of admission. Approximately 100 patients undergo this operation annually in the trust. We need to recruit at least 54 patients and we would hope to achieve this over 1 year.
Key exclusion criteriaPatients will be excluded if they have a contraindication to a block, such as coagulopathy, thrombocytopenia, treatment with clopidogrel or multiple anti-platelet agents within one week of surgery. Other exclusions will be patient refusal and known local anaesthetic allergy. In order to account for the potential influence of beta-blockade, only patients on perioperative beta blockade will be studied. Patients will therefore be excluded if they have a contraindication to beta-blockade.

1. Patients will be excluded if they do not wish to take part in this trial
2. Contra-indication to beta blockage therapy
3. Increase risk of bleeding (ie patients with low platelet counts , coagulopathy associated with liver dysfunction, treatment with multiple antiplatelet agents or treatment with clopidogrel in the 7 days prior to surgery)
4. Patients with known allergy to local anaesthetics
Date of first enrolment01/09/2004
Date of final enrolment30/09/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

South Tees Hospital Trust
Middlesbrough
TS4 3BW
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

South Tees Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan